Live Biotech updates

Live Biotech news coverage of developments with the latest updates. Stay on top of latest Biotech news stories and find out what just happened, what is going on with Biotech. The latest real-time news updates and headlines on Biotech
New Tech Tackles Bottlenecks in Blood Cancer Treatment
Alterity Therapeutics Posts Positive MSA Trial Interim Data
De Motu Cordis Advances New Anaphylaxis Treatment in QLD
Burnet Officer Wins Moderna Global Fellowship
Input Sought for National Health & Medical Research Audit
Sullivan Inaugurates Americas Partnership Angel Network
Academy's Advice Informed Australia's RNA Blueprint
King's EPSRC Centre Joins Forces With Banking Start-up
Global Evidence Leaders Unite for Health, Beyond
Bird Flu Not Spreading in Humans, Vaccines in Pipeline
E. Coli Variant Linked to Antimicrobial Resistance in Pets, Humans
SOTIO, Biocytogen Ink Multi-Target Antibody Deal
Merck Expands NZ Employee Fertility Benefits
Immutep Reports Positive Combo Cancer Therapy Results
Dimerix Awarded Bioshares Excellence Award
New Perth Based RNA Facility To Improve Cancer Outcomes
Hub Opens Opportunities For New Disease Treatments
WA Secures Prestigious National Biotech Summit
Telix Applauds CMS Move To Boost Diagnostic Radiopharma Pay
Orthocell Gains Nod to Sell Striate+ in Canada
Nominations Open for MRFF and NHMRC Advisory Committees
Canada, BC, Aspect Biosystems Partner for Health Innovation
New Co-STAR Receptor Shows Promise in Lab Cancer Study
Advancement in High-Tech Kidney Disease Urine Test
Orthocell Reports Record Quarterly And Yearly Revenue
GeneType Expands to Canada, New Zealand Markets
Dr James Campbell Appointed AusBiotech Chair
UC 1819 Hub Drives Cincinnati Startup Boom
Florey Biotech Spin-Out Gains Seed Funding From Curie.Bio
Potential New Test For Kidney Disease
Amplia Completes Recruitment for Phase 2 Trial's First 26
Amplia Completes Recruitment for Phase 2 Trial's First 26
Dimerix to Begin Recruiting Teens for Phase 3 Trial
Top Performing ASX Companies
AusBiotech: Five New Additions Bolster BioMelbourne Board
Actinogen Completes Final Patient Visit in Phase 2a Depression Trial
Sydney Viral Vector Facility Appoints First CEO
Prof. Peter Van Wijngaarden Named Florey's Next Director, CEO
Lab Study: Functional Sort Boosts Stem Cell Heart Attack Healing
How 5 UNM Inventions Could Change World
University Launches New Biotech Spin-out Company
Actinogen's Xanamem Phase 2a Trial Success Published in Journal
CUREator+ Offers Funding for Dementia, Cognitive Decline Innovations
Immutep Reveals TACTI-003 Phase 2b Trial Topline Results
Members Sought For New Policy Taskforce
Psylo Partners for Psychedelic Mental Health Treatments
Quantum Seed Grants Fund Real-World Problem Solutions
RoslinCT Names Prof. Mathieson, Vos as New Non-Exec Directors